DK0817860T3 - Pseudotype retrovirale partikler - Google Patents

Pseudotype retrovirale partikler

Info

Publication number
DK0817860T3
DK0817860T3 DK96909135T DK96909135T DK0817860T3 DK 0817860 T3 DK0817860 T3 DK 0817860T3 DK 96909135 T DK96909135 T DK 96909135T DK 96909135 T DK96909135 T DK 96909135T DK 0817860 T3 DK0817860 T3 DK 0817860T3
Authority
DK
Denmark
Prior art keywords
retroviral particles
retroviral vector
virus
mlv
vector system
Prior art date
Application number
DK96909135T
Other languages
Danish (da)
English (en)
Inventor
Brian Salmons
Joerg Baumann
Original Assignee
Austrian Nordic Biotherapeutic
Gsf Forschungszentrum Umwelt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Austrian Nordic Biotherapeutic, Gsf Forschungszentrum Umwelt filed Critical Austrian Nordic Biotherapeutic
Application granted granted Critical
Publication of DK0817860T3 publication Critical patent/DK0817860T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/13011Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13051Methods of production or purification of viral material
    • C12N2740/13052Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Optical Radar Systems And Details Thereof (AREA)
  • Eye Examination Apparatus (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dental Preparations (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
DK96909135T 1995-03-29 1996-03-27 Pseudotype retrovirale partikler DK0817860T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK32795 1995-03-29
PCT/EP1996/001348 WO1996030533A1 (fr) 1995-03-29 1996-03-27 Particules retrovirales pseudotypees

Publications (1)

Publication Number Publication Date
DK0817860T3 true DK0817860T3 (da) 2001-10-01

Family

ID=8092296

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96909135T DK0817860T3 (da) 1995-03-29 1996-03-27 Pseudotype retrovirale partikler

Country Status (8)

Country Link
EP (1) EP0817860B1 (fr)
JP (1) JPH11502706A (fr)
AT (1) ATE200912T1 (fr)
AU (1) AU5274696A (fr)
DE (1) DE69612660T2 (fr)
DK (1) DK0817860T3 (fr)
ES (1) ES2157435T3 (fr)
WO (1) WO1996030533A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7470096A (en) * 1995-10-05 1997-04-28 Chiron Corporation Retroviral vectors pseudotyped with srv-3 envelope glycoprotein sequences
ATE207963T1 (de) 1997-02-27 2001-11-15 Bundesrepublik Deutschland Let Retrovirale vektoren, verfahren zu ihrer herstellung und ihre verwendung zur genübertragung in cd4-positive zellen
EP0938904A1 (fr) * 1998-02-09 1999-09-01 Leuven Research & Development vzw Transduction des cellules mammifères pour utilisation dans la thérapie génique
CA2289918A1 (fr) * 1997-05-16 1998-11-26 Leuven Research & Development Vzw Transduction de cellules de mammiferes utilisee en therapie genique
FR2779445B1 (fr) * 1998-06-08 2000-08-11 Univ Nantes Kit d'encapsidation
GB0400443D0 (en) 2004-01-09 2004-02-11 Oxford Biomedica Ltd Cascade
EP1427836A2 (fr) * 2001-09-21 2004-06-16 Oxford Biomedica (UK) Limited Systeme de vecteurs retroviraux pseudotypes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69420033T2 (de) * 1993-04-06 1999-12-23 Us Gov Health & Human Serv Gibbon leukemia virus retrovirale vektoren

Also Published As

Publication number Publication date
AU5274696A (en) 1996-10-16
ATE200912T1 (de) 2001-05-15
DE69612660T2 (de) 2002-04-18
EP0817860A1 (fr) 1998-01-14
JPH11502706A (ja) 1999-03-09
DE69612660D1 (de) 2001-06-07
ES2157435T3 (es) 2001-08-16
EP0817860B1 (fr) 2001-05-02
WO1996030533A1 (fr) 1996-10-03

Similar Documents

Publication Publication Date Title
GB2331522A (en) Lentiviral vectors
DE69535669D1 (de) Retrovirale vektoren mit verminderter rekombinationsrate
ES2153654T3 (es) Vectores retrovirales.
CA2324028A1 (fr) Lignees de cellules retrovirales d'encapsidation
ATE291632T1 (de) Auf lentivirus basierende gentransfer-vektoren
DK1076715T3 (da) Lentivirale pakkeceller
FR2731013B1 (fr) Vih-1 de groupe o, fragments desdits virus, ainsi que leurs applications
DK0817860T3 (da) Pseudotype retrovirale partikler
NO975813D0 (no) Innkapslede celler som produserer virale partikler
DE69739251D1 (de) Nicht-m nicht-o hiv-1-stamm, fragmente und verwendungen
ES2167072T3 (es) Vectores retrovirales, procedimientos para su preparacion y su utilizacion para la transmision de genes a celulas cd-4 positivas.
WO2002042482A3 (fr) Vecteur lentiviral fonctionnel a partir d'un squelette base sur mlv
ES2184059T3 (es) Vector retrovirico y su utilizacion en terapia genica.
NO20002013D0 (no) Suspensjonsforpakningscellelinjer for retrovirusvektorer
WO1995025806A3 (fr) Lentivirus a encapsidation deficiente
AR020076A1 (es) LíNEA CELULAR DE EMPAQUETAMIENTO DE RETROVIRUS ANFOTRoPICO, PROCESO PARA SU PRODUCCIoN, Y PROCESO PARA LA PRODUCCIoN DE UN VECTOR RETROVIRAL MEDIANTE LA MISMA.
WO2002034929A3 (fr) Vecteurs d'expression et leurs utilisations
ATE239074T1 (de) Transduktion von menschlichen hämatopoiestischen stammzellen
WO1999025862A3 (fr) SIGNAL D'ENCAPSIDATION VIRALE CHIMERE SANS SEQUENCES DE GENE $i(GAG)
EP1129100A4 (fr) Systeme de selection pour la production de cellules d'encapsidation efficace pour vecteurs lentiviraux